An international team of researchers identifies a compound that corrects genetic abnormalities involved in the onset and progression of Huntington’s disease for which there is no definitive treatment. They successfully reversed disease-causing DNA expansion mutations with no off-target effects in the lab. They hope that their discovery may help treat other DNA repeat diseases like myotonic dystrophy.